View Document Preview and Link Document Date: 2014-02-21 16:06:36 Open Document File Size: 65,23 KB Share Result on Facebook
Company Glynn SA / / Continent Asia / South America / / Country United States / / IndustryTerm cell-containing blood products / / MedicalCondition potential donor-derived disease / transfusion-transmissible viral infections / unexplained neurological disease / T-cell leukemia/lymphoma / spastic paraparesis / disease / donor infection / inflammatory disorders / local transplant infectious disease / neurological disease / viremia / myelopathy / donor-derived infection / Proven Disease / acute T-cell leukemia/lymphoma / Donor Disease / infection / human disease / / MedicalTreatment immunosuppression / organ transplant / / Organization American Association of Tissue Banks / U.S. Food and Drug Administration / US Federal Reserve / Organ Procurement Organization / FDA / OPTN/UNOS Executive Committee / Ad Hoc Disease Transmission Advisory Committee / / Position Busch MP / / Region Caribbean / West Africa / Oceania / / Technology antibodies / transplantation / / URL www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/TissueSafety/ucm095440.htm?sms_ss / / SocialTag 
OPTN Guidance for HTLV-1 Screening and Confirmation in Potential Donors